Case report: Durable response of ensartinib targeting EML4-ALK fusion in osimertinib-resistant non-small cell lung cancer
Article in Frontiers in Pharmacology (July 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Article in Frontiers in Pharmacology (July 2024)
Article in Translational Lung Cancer Research (December 2023)
Article in JCO Precision Oncology (September 2023)